Imagine the pain of severe mouth sores making it impossible to eat or drink during cancer treatment. That's radiation-induced oral mucositis, a common and debilitating side effect for people getting radiation for head and neck cancer. A small, early-stage trial tested whether a simple preventive measure—rinsing with a steroid mouthwash—could help.
The study involved 50 patients who were scheduled for intensive radiation. Half used a mouthwash containing the steroid dexamethasone four times a day, while the other half used a placebo. The results were encouraging: those using the steroid rinse developed less severe mouth sores overall. Their pain scores were lower from weeks four through seven, and the peak severity of their sores was delayed by about two weeks. Notably, no one in the steroid group developed the most severe grade of mucositis, while two people in the placebo group did. The mouthwash was well-tolerated, with no sign of increased oral infections or systemic steroid side effects.
It's important to view these findings as a promising first step, not a final answer. This was a phase II study with only 50 patients, so the results need to be confirmed in much larger, longer trials. The researchers also note they didn't compare the mouthwash to other recommended strategies, like special light therapy. We don't yet know about any long-term effects. For now, this offers a hopeful glimpse at a potential new tool to ease a major source of suffering during cancer treatment.